The pioglitazone safety warning issued in South Korea, which recommended prescribing with careful attention among those with high risk of bladder cancer, led to a moderate decrease in pioglitazone users.
Ju-Young Shin, PhD
Advertisement
Articles by Ju-Young Shin, PhD
Codeine was frequently prescribed for children in Korea despite the actions taken to restrict its use in that age group in Korea and other countries.
The prevalence and predictors of hypoglycemia in South Korean patients with type 2 diabetes were evaluated using a nationwide healthcare database.
Advertisement
Latest Updated Articles
- Prevalence and Predictors of Hypoglycemia in South Korea
Published: June 12th 2018 | Updated:
- Pediatric Codeine Prescriptions in Outpatient and Inpatient Settings in Korea
Published: August 8th 2019 | Updated:
- Prescribing Trend of Pioglitazone After Safety Warning Release in Korea
Published: November 19th 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Cancer Care in Transition: Navigating Breakthrough Therapies Amid Economic Strain
4
Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes
5
